Collaborative Treatment Considerations for the Optometrist in Relapsed/Refractory Multiple Myeloma: Mitigating and Managing Ocular Adverse Events | March 8, 2023

Collaborative Treatment Considerations for the Optometrist in Relapsed/Refractory Multiple Myeloma: Mitigating and Managing Ocular Adverse Events | March 8, 2023

Objectives

Content

Faculty

Credibility

Objectives

Content

Faculty

Credibility

Join our newsletter

Name*

First Last

Name as it should appear on certificate*

Email*

What is your profession?*

Optometrist (COPE)
Certificate of Attendance

OE TRACKER NUMBER

Date of Birth

How long did it take you to complete this activity?

Hours*

HH:MM

The course met the stated learning objectives:

1. Review the patient, disease, and treatment factors prescribers consider when managing patients with relapsed/refractory multiple myeloma*

2. Discuss the newer B cell maturation antigen (BCMA)-targeted immunotherapies for RRMM, including their mechanism of action and updated efficacy and safety data from pivotal clinical trials.*

3. Discuss common ocular adverse effects seen with anti-BCMA therapies and explore appropriate monitoring and mitigation strategies to combat these while optimizing therapy.*

4. Examine synergistic strategies for challenging RRMM patient cases, with a focus on optometrist collaborative approaches with the oncologist and others on the patient care team.*

Please rate your level of agreement with the following statements. This activity…

Helped me to have a better understanding of the topic(s).*

Assisted me to consider using the information in a different way to improve my practice.*

Provided me with resources I can use in my daily practice or with my patients.*

Will support my routine clinical practice to deliver evidence-based, best practice that improves patient health outcomes.*

Please rate the quality of the faculty, from 5 (Excellent) to 1 (Poor).

Soroosh Behshad, MD, MPH*

Will you change the way you practice based on this activity?*

Yes
No

Do you feel the activity was balanced and objective?*

Yes
No

Do you feel the activity was free of commercial bias?*

Yes
No

Approximately what percent of this content was NEW to you?*

As compared to other CME activities you have participated in the past six months, do you believe this activity:*

Increased your knowledge
Will improve patient outcomes in your practice

What I liked about this activity…? (Select all that apply)*

It allowed me to interact with my peers and faculty
It provided feedback throughout the activity
It provided information in ways that I can review again later
It gave me the opportunity to apply information to realistic scenarios that I confront in my practice
It facilitated the sharing of experiences and best practices

In the past six months, how many CME programs have you participated in?*

What was the most useful information you gained from this activity?

Clinical Relevance

Teaching Strategies

Level of Expertise